These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 8869473

  • 21. Porcine factor VIII therapy in patients with congenital hemophilia and inhibitors: efficacy, patient selection, and side effects.
    Hay CR, Lozier JN, Lee CA, Lafan M, Tradati H, Santagostino E, Ciavarella N, Schiavoni M, Fukui H, Yoshioka A.
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):20-5. PubMed ID: 7939768
    [No Abstract] [Full Text] [Related]

  • 22. Immune tolerance induction with highly purified plasma-derived factor VIII containing von Willebrand factor in hemophilia A patients with high-responding inhibitors.
    Orsini F, Rotschild C, Beurrier P, Faradji A, Goudemand J, Polack B.
    Haematologica; 2005 Sep; 90(9):1288-90. PubMed ID: 16154861
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Immune tolerance induction with high von Willebrand factor/factor VIII content ratio concentrate in children with haemophilia A and high-responding inhibitor.
    Platokouki H, Pergantou H, Xafaki P, Komitopoulou A, Aronis S.
    Haemophilia; 2009 Mar; 15(2):617-9. PubMed ID: 19175417
    [No Abstract] [Full Text] [Related]

  • 27. Spontaneous disappearance of high titre factor VIII inhibitor 15 years after unsuccessful ITI.
    Thom K, Male C, Falger J, Pabinger I.
    Hamostaseologie; 2009 May; 29(2):149-50. PubMed ID: 19404512
    [Abstract] [Full Text] [Related]

  • 28. Immune tolerance in two high responder, severe hemophilia A patients with inhibitors: the importance of high doses and the duration of the treatment.
    Ciavarella N, Schiavoni M, Fasano A, Giliberti MG, Ettorre C, Stefanile C.
    Vox Sang; 1996 May; 70 Suppl 1():72-3. PubMed ID: 8869475
    [No Abstract] [Full Text] [Related]

  • 29. Factor VIII inhibitors. Immune tolerance induction: is it cost effective? We know too little.
    Aledort LM.
    Semin Thromb Hemost; 2000 May; 26(2):189-93. PubMed ID: 10919412
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Single-dose pharmacokinetics of porcine factor VIII (Hyate C).
    Hermans C, Owens D, Longo G, Morfini M, Lee CA.
    Thromb Haemost; 2002 Feb; 87(2):352-3. PubMed ID: 11858504
    [No Abstract] [Full Text] [Related]

  • 32. Porcine factor VIII: preparation and use in treatment of inhibitor patients.
    Kernoff PB.
    Prog Clin Biol Res; 1984 Feb; 150():207-24. PubMed ID: 6431429
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Acquired hemophilia and its treatment.
    Sultan Y.
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S15-8. PubMed ID: 9351531
    [Abstract] [Full Text] [Related]

  • 35. Immune response induced by porcine factor VIII in severe hemophiliacs with antibody to F VIII.
    Verroust F, Allain JP.
    Thromb Haemost; 1982 Oct 29; 48(2):238. PubMed ID: 6817447
    [No Abstract] [Full Text] [Related]

  • 36. Hemophilia care in the 21st century.
    Kempton CL, Escobar MA, Roberts HR.
    Clin Adv Hematol Oncol; 2004 Nov 29; 2(11):733-40. PubMed ID: 16170890
    [No Abstract] [Full Text] [Related]

  • 37. von Willebrand factor: what is its role in the immune response in haemophilia?
    Kaveri S, Mannucci PM, Kurth MH, Ewing N, Kessler CM, Nugent DJ, Gomperts ED.
    Haemophilia; 2011 Jan 29; 17(1):e235-8. PubMed ID: 20546026
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.